Reply to 'Comment on 'Distinct clinical outcomes of two CIMP-positive colorectal cancer subtypes based on a revised CIMP classification system"

Jeong Mo Bae^{1

2}, Jung Ho Kim^{1

3}, Yoonjin Kwak^{3

4}, Dae-Won Lee⁵, Yongjun Cha⁵, Xianyu Wen¹, Tae Hun Lee¹, Nam-Yun Cho¹, Seung-Yong Jeong⁶, Kyu Joo Park⁶, Sae Won Han⁵, Hye Seung Lee^{3

4}, Tae-You Kim⁵, Gyeong Hoon Kang^{1

3}

Affiliations

¹ Laboratory of Epigenetics, Cancer Research Institute, Seoul National University College of Medicine, Seoul 03080, South Korea.
² Department of Pathology, SMG-SNU Boramae Medical Center, Seoul 07061, South Korea.
³ Department of Pathology, Seoul National University College of Medicine, Seoul 03080, South Korea.
⁴ Department of Pathology, Seoul National University Bundang Hospital, Seongnam 13620, South Korea.
⁵ Department of Internal Medicine, Seoul National University Hospital, 'Seoul 03080, South Korea.
⁶ Department of Surgery, Seoul National University Hospital, Seoul 03080, South Korea.

Comment

Jeong Mo Bae et al. Br J Cancer. 2018.

. 2018 Feb 6;118(3):e4.

doi: 10.1038/bjc.2017.426. Epub 2018 Jan 2.

¹ Laboratory of Epigenetics, Cancer Research Institute, Seoul National University College of Medicine, Seoul 03080, South Korea.
² Department of Pathology, SMG-SNU Boramae Medical Center, Seoul 07061, South Korea.
³ Department of Pathology, Seoul National University College of Medicine, Seoul 03080, South Korea.
⁴ Department of Pathology, Seoul National University Bundang Hospital, Seongnam 13620, South Korea.
⁵ Department of Internal Medicine, Seoul National University Hospital, 'Seoul 03080, South Korea.
⁶ Department of Surgery, Seoul National University Hospital, Seoul 03080, South Korea.

No abstract available

Conflict of interest statement

The authors declare no conflict of interest.

Distinct clinical outcomes of two CIMP-positive colorectal cancer subtypes based on a revised CIMP classification system.
Bae JM, Kim JH, Kwak Y, Lee DW, Cha Y, Wen X, Lee TH, Cho NY, Jeong SY, Park KJ, Han SW, Lee HS, Kim TY, Kang GH. Bae JM, et al. Br J Cancer. 2017 Apr 11;116(8):1012-1020. doi: 10.1038/bjc.2017.52. Epub 2017 Mar 9. Br J Cancer. 2017. PMID: 28278514 Free PMC article.
Comment on 'Distinct clinical outcomes of two CIMP-positive colorectal cancer subtypes based on a revised CIMP classification system'.
Tapial S, Rueda D, Arriba M, Luis García J, Brandáriz L, Pérez J, Rodríguez Y, García-Olmo D, González-Sarmiento R, Urioste M, Perea J. Tapial S, et al. Br J Cancer. 2018 Feb 6;118(3):e3. doi: 10.1038/bjc.2017.343. Epub 2018 Jan 2. Br J Cancer. 2018. PMID: 29384528 Free PMC article. No abstract available.

1. Arriba M, Sanchez R, Rueda D, Gomez L, Garcia JL, Rodriguez Y, Pajares JA, Perez J, Urioste M, Sarmiento RG, Perea J (2017) Toward a molecular classification of synchronous colorectal cancer: clinical and molecular characterization. Clin Colorectal Cancer 16(1): 31–37. - PubMed
1. Chan TL, Curtis LC, Leung SY, Farrington SM, Ho JW, Chan AS, Lam PW, Tse CW, Dunlop MG, Wyllie AH, Yuen ST (2001) Early-onset colorectal cancer with stable microsatellite DNA and near-diploid chromosomes. Oncogene 20(35): 4871–4876. - PubMed
1. Cybulski C, Nazarali S, Narod SA (2014) Multiple primary cancers as a guide to heritability. Int J Cancer 135(8): 1756–1763. - PubMed
1. de Voer RM, Hahn MM, Weren RD, Mensenkamp AR, Gilissen C, van Zelst-Stams WA, Spruijt L, Kets CM, Zhang J, Venselaar H, Vreede L, Schubert N, Tychon M, Derks R, Schackert HK, Geurts van Kessel A, Hoogerbrugge N, Ligtenberg MJ, Kuiper RP (2016) Identification of novel candidate genes for early-onset colorectal cancer susceptibility. PLoS Genet 12(2): e1005880. - PMC - PubMed
1. McGivern A, Wynter CV, Whitehall VL, Kambara T, Spring KJ, Walsh MD, Barker MA, Arnold S, Simms LA, Leggett BA, Young J, Jass JR (2004) Promoter hypermethylation frequency and BRAF mutations distinguish hereditary non-polyposis colon cancer from sporadic MSI-H colon cancer. Fam Cancer 3(2): 101–107. - PubMed